Shinva Medical Instrument Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	2,752	2,945	3,188	1,689	1,567	1,351
Short-Term Investments	-	-	-	-	10	-
Trading Asset Securities	16.3	1.03	100.1	100.31	98.07	41.7
Cash & Short-Term Investments	2,768	2,946	3,288	1,789	1,675	1,392
Cash Growth	9.88%	-10.42%	83.78%	6.81%	20.32%	17.67%
Accounts Receivable	2,301	2,306	2,110	2,004	1,772	1,751
Other Receivables	528.79	461.42	238.49	235.97	181.24	163.04
Receivables	2,830	2,768	2,348	2,240	1,953	1,914
Inventory	3,141	3,356	3,556	3,029	2,306	2,342
Prepaid Expenses	-	2.02	0.18	0.07	0.01	-
Other Current Assets	230.79	294.27	261.95	327.01	243.2	178.17
Total Current Assets	8,970	9,366	9,454	7,385	6,177	5,827
Property, Plant & Equipment	3,254	3,181	3,013	2,526	2,396	2,471
Long-Term Investments	1,546	1,640	1,787	1,712	1,684	1,852
Goodwill	242.04	242.04	257.26	268.76	268.76	268.76
Other Intangible Assets	451.47	469.87	478.06	478.53	461.25	523.45
Long-Term Accounts Receivable	10.55	9.38	14.78	1.37	28.92	2.56
Long-Term Deferred Tax Assets	116.2	122.45	115.96	90.34	69.66	111.04
Long-Term Deferred Charges	124.7	123.24	123.33	132.28	148.63	157.38
Other Long-Term Assets	364.57	373.08	346.4	366.56	378.67	340.4
Total Assets	15,079	15,526	15,590	12,961	11,614	11,554
Accounts Payable	2,423	2,754	2,443	2,497	2,193	1,964
Accrued Expenses	190.52	440.29	508.64	450.4	333.52	285.96
Short-Term Debt	922.12	900.61	871.95	986.4	926.39	1,812
Current Portion of Long-Term Debt	96.99	107	28.47	59.23	94.32	-
Current Portion of Leases	-	17.98	22.82	21.39	17.34	-
Current Income Taxes Payable	62.51	39.37	31.96	32.63	67.47	87.66
Current Unearned Revenue	1,757	2,049	2,336	2,042	1,761	1,400
Other Current Liabilities	1,124	928.1	1,254	817.42	627.9	515.34
Total Current Liabilities	6,576	7,237	7,498	6,906	6,021	6,065
Long-Term Debt	88.89	80.48	137.8	96.33	58.66	412.75
Long-Term Leases	47.79	29.83	37.95	29.37	89.77	0.63
Long-Term Unearned Revenue	79.42	78.76	61.67	52.62	53.69	104.19
Long-Term Deferred Tax Liabilities	100.16	94.87	96.04	82.75	116.04	102.43
Other Long-Term Liabilities	22.02	22.77	39.44	6.4	6.4	10.65
Total Liabilities	6,914	7,544	7,870	7,174	6,345	6,696
Common Stock	606.68	606.68	466.68	411.97	406.43	406.43
Additional Paid-In Capital	2,650	2,716	3,000	1,723	1,667	1,672
Retained Earnings	4,607	4,324	3,867	3,283	2,838	2,303
Treasury Stock	-18.32	-37.8	-60.28	-62.46	-	-
Comprehensive Income & Other	-13.37	-11.41	45.08	35.49	3.48	3.87
Total Common Equity	7,831	7,597	7,319	5,391	4,915	4,385
Minority Interest	333.36	385.5	401.21	396.27	353.72	473.52
Shareholders' Equity	8,164	7,983	7,720	5,787	5,268	4,858
Total Liabilities & Equity	15,079	15,526	15,590	12,961	11,614	11,554
Total Debt	1,156	1,136	1,099	1,193	1,186	2,225
Net Cash (Debt)	1,612	1,810	2,189	596.64	488.82	-832.56
Net Cash Growth	13.52%	-17.34%	266.96%	22.06%	-	-
Net Cash Per Share	2.43	2.98	3.65	1.13	0.93	-1.59
Filing Date Shares Outstanding	606.68	606.68	606.69	606.94	535.57	528.36
Total Common Shares Outstanding	606.68	606.68	606.69	535.57	528.36	528.36
Working Capital	2,394	2,129	1,957	478.72	156.3	-238.05
Book Value Per Share	12.91	12.52	12.06	10.07	9.30	8.30
Tangible Book Value	7,138	6,885	6,583	4,644	4,185	3,592
Tangible Book Value Per Share	11.77	11.35	10.85	8.67	7.92	6.80
Buildings	-	2,711	2,148	2,114	2,071	-
Machinery	-	1,357	1,351	1,212	1,117	-
Construction In Progress	-	466.9	739.97	304.46	122.97	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.